TW200513649A - Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol - Google Patents

Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol

Info

Publication number
TW200513649A
TW200513649A TW093119962A TW93119962A TW200513649A TW 200513649 A TW200513649 A TW 200513649A TW 093119962 A TW093119962 A TW 093119962A TW 93119962 A TW93119962 A TW 93119962A TW 200513649 A TW200513649 A TW 200513649A
Authority
TW
Taiwan
Prior art keywords
biological molecules
flux rates
vivo
methods
comparing relative
Prior art date
Application number
TW093119962A
Other languages
English (en)
Inventor
Marc K Hellerstein
Original Assignee
Univ California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ California filed Critical Univ California
Publication of TW200513649A publication Critical patent/TW200513649A/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
TW093119962A 2003-07-03 2004-07-02 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol TW200513649A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US48462603P 2003-07-03 2003-07-03

Publications (1)

Publication Number Publication Date
TW200513649A true TW200513649A (en) 2005-04-16

Family

ID=34102659

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093119962A TW200513649A (en) 2003-07-03 2004-07-02 Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol

Country Status (2)

Country Link
TW (1) TW200513649A (zh)
WO (2) WO2005009597A2 (zh)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5910403A (en) 1997-05-15 1999-06-08 The Regents Of University Of California Methods for measuring cellular proliferation and destruction rates in vitro and in vivo
EP1437966B1 (en) 2001-10-24 2011-03-23 The Regents of The University of California Measurement of protein synthesis rates in humans and experimental systems by use of isotopically labeled water
WO2004011426A2 (en) 2002-07-30 2004-02-05 The Regents Of The University Of California Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry
DK1546373T3 (da) 2002-09-13 2009-03-30 Univ California Fremgangsmåder til måling af hastigheder af revers cholesteroltransport in vivo som et indeks for antiatherogenese
US7262020B2 (en) 2003-07-03 2007-08-28 The Regents Of The University Of California Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
US20050202406A1 (en) 2003-11-25 2005-09-15 The Regents Of The University Of California Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems
TW200538738A (en) 2004-02-20 2005-12-01 Univ California Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
US10386371B2 (en) 2011-09-08 2019-08-20 The Regents Of The University Of California Metabolic flux measurement, imaging and microscopy
US20140353486A1 (en) 2011-12-07 2014-12-04 Glaxosmithkline Llc Methods for determining total body skeletal muscle mass
US9134319B2 (en) 2013-03-15 2015-09-15 The Regents Of The University Of California Method for replacing biomarkers of protein kinetics from tissue samples by biomarkers of protein kinetics from body fluids after isotopic labeling in vivo

Also Published As

Publication number Publication date
WO2005015155A2 (en) 2005-02-17
WO2005009597A2 (en) 2005-02-03
WO2005015155A3 (en) 2005-08-04

Similar Documents

Publication Publication Date Title
WO2005033652A3 (en) Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
NO20034020L (no) Nye MHC molekylforbindelser, og metoder for anvendelse av disse forbindelsene for diagnose og terapi, og anvendelse av MHC molekyler
DE60028830D1 (de) Anti-april antikörper und hybridomazellen
WO2006134390A3 (en) Method for diagnosing neurodegenerative disease
WO2008069975A3 (en) Methods of using f-spondin as a biomarker for cartilage degenerative conditions
WO2005052592A3 (en) Methods for diagnosis, stratification, and monitoring of alzheimer’s disease
WO2006073682A3 (en) Diagnostic test
EA200800490A1 (ru) НОВЫЕ ПРОИЗВОДНЫЕ БЕНЗО[d][1,3]ДИОКСОЛА
DK1421215T3 (da) Fremgangsmåder til evaluering af patologiske tilstande under anvendelse af ekstracellulært RNA
TW200513649A (en) Methods for comparing relative flux rates of two or more biological molecules in vivo through a single protocol
DE602007011566D1 (en) Ankheit
NO20074515L (no) Fremgangsmate til prognose for mentale sykdommer, f.eks. autisme og cerebral parese
WO2008021515A3 (en) Methods of determining levels of free amino acids and dipeptides and diagnosing alzheimer's diseases
ATE451475T1 (de) Verfahren und systeme zur diagnose von nicht das zentrale nervensystem (zns) betreffenden krankheiten in zns-proben
WO2006130527A3 (en) Mutations and polymorphisms of fibroblast growth factor receptor 1
EP2044212A4 (en) METHOD FOR IDENTIFYING PATIENTS WITH INCREASED RISK FOR AN UNWANTED HEART CIRCUIT EVENT
WO2006110478A3 (en) Mutations and polymorphisms of epidermal growth factor receptor
ATE472611T1 (de) Verfahren zur diagnose von sepsis durch analyse von cytokine mrna expression
WO2007022041A3 (en) Mutations and polymorphisms of hdac3
BR0317404A (pt) Variantes do fator xiia
WO2004066823A3 (en) Methods and compositions for analysis of mitochondrial-related gene expression
WO2007038073A3 (en) Mutations and polymorphisms of hdac11
WO2003086563A3 (en) Diabetes imaging probes
WO2006046270A3 (en) Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
DE60026743D1 (de) Verwendung von kontrastmitteln zur herstellung eines diagnostischen mittels für die darm-lumenbildgebung